02185.HK
Shanghai Bio-heart Biological Technology Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 1.47
−8.13%Margins
Gross margin
-2.3%
EBITDA margin
-175.1%
EBIT margin
-228.9%
Net margin
-196.4%
FCF margin
-172.3%
-18.5%
Return on equity
-9.4%
Return on assets
-20.9%
Return on invested capital
0.05x
Asset turnover
-HKD 67.7M
Cash from operations
HKD 1.14
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026